FDA Investigator Kimberley A Hoefen

Kimberley A Hoefen has inspections in 4 countries as of 23 Aug 2023. Kimberley A Hoefen has collaborated with a combinined 5510 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
116
Last Inspection Date:
23 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
100003706
Country:
United States of America, Netherlands, Finland, Germany
Co-Investigator(s):
Alan M Barker, Alan P Kurtzberg, Aliza Chalapong Asawesna, Ana C Lazo, Ana P Barido, Andrea Ab Bautista, Andrea J Schmidt, Andrea S Heise, Andrew J Gonzales, Andrew M Kolenc, Anita Narula, PhD, Ann Marie Montemurro, Anthony A Charity, Anthony J Lagreca, Arie C Menachem, Arthur G Hurst, Ashleigh P Barkans, Ashleigh P Wodushek, Ashley M Caputo, Barbara J Holladay, Barbara Janine Breithaupt, Betty K Baxter, Bodenw, Bonita S Chester, Brandon C Heitmeier, Brandon K Lawson, Brent W Higgs, Brian S Erickson, Brittany R Laymon, Bryan A Galvez, Bryan G Hills, Bryan J Love, Bryce A Hammer, Carla Lankford, MD, PhD, Carla R Hinz, Carlos Chavez, Carmen Y Fisher, Caroline H Le, Carrie E Jolly, Carterm, Caryn M Mcnab, CDR Ileana Barreto Pettit, Chani Broner, PhD, Charles L Zhou, Chet A Fitzgerald, Christie A Soto, Christin L Torres, Christina A Mayer, Christine I Shaw, Christine L Williams, Christopher M Jenner, Cynthia Jim, CSO, Dan Myt Chu, CTP, Daniel J Lahar, Daniel Pst Laurent, Danielle Lyke, David A Gonzalez, David Faranda, David Frucht, MD, David M Beltran, Deborah S Hammond, Debra I Love, Debra L Curtis, Dennis Cantellops Paite, Diana M Guidry, Diana M Raman, Donald R Hawn, Dongping Dai, PhD, Douglas A Campbell, Dr. Gang Wang, PhD, Dr. Robert C Horan, MD, Duc Minh H Nguyen, Dustin M James, Edith M Gonzalez, Elena Karnaukhova, PhD, Elisa J Beard, Elizabeth D Gonzales, Elizabeth R Pepinsky, Elvin R Smith, Emil P Wang, JD, Eric S Myskowski, Erica R Woody, Erika V Butler, Esther C Broner, PhD, Farhana Khan, Felix J Marrero, Frank L Cordova, Frank W Perrella, Frans E Mercado, Frederick L Fricke, Gabriel E Muniz, Gary C Pecic, Genoula K Ryan, Gerard T Schneider, Gina M Scholze, Ginger M Sykes, Grace E Mcnally, Gwyn G Dickinson, Hamet M Toure, PharmD MPH, Hanna L Potter, Haroon Vohra (NMI), Holly L Miller, Isabel Y Espinosa, Jacqueline Mdiaz Albertini, James A Lentz, James D Bradley, James D Planchon, James L Dunnie, Jr, James R Montero, Jamie L Dion, Janet Pulver, Jason D Tenney, Jennifer A Baker, Jennifer A Robinson, Jennifer L Wolfe, Jennifer R Mathern, Jessica M Ector, Jessie E Morris, Jianming Li, Jin M Kim, Johnson, Johnsont, Jonathan R Campos, Jorge L Guadalupe, Jose Acruz Gonzalez, Juan A Morales, Julia D Cartwright, June P Page, Justin A Hefferman, Justin H Erickson, Justin R Carr, Kalavati Suvarna, PhD, Karen A Wolnik, Karen G Hirshfield, Katherine Szestypalow, Kathleen D Culver, Kathryn M Mogen, Kelly D Moore, Kenneth V Miller, Kent C Faul, Kerry L Edwards, III, Kevin D Kallander, Kham Phommachanh, Khumo A Phake, Kimberley Buylaert Hoefen, Kimberly A Hoefen, Kimberly Abuytaert Hoefen, Kimberly Cdelk Brooks, Kimerley A Hoefen, Kristen E Szenderski, La Tasha M Gunter, Larisa E Pavlick, Larry Gehring, Laura B Kennedy, Laura L Staples, Laura L Van Wagenen, Lauren Ciurca, CTP, Lauren R Howell, Lavender M Huskey, LCDR Audra J Lenhart, Lewis K Antwi, Liatte Kreuger, PharmD, Linda F Murphy, Linda M Cheny, Linda S Mattingly, Linhart, Lisa Shin, Lloyd D Payne, Lori A Carr, Luis M Burgos Medero, Manuel A Moreno, Marc A Jackson, Jr, Marcus F Yambot, Margaret M Annes, Marie Bbuen Bigornia, Marijo B Kambere, PhD, Marion W Nadeau, Marisol Faberlle, Mariza M Jafary, Marlene G Swider, Marsha L Mccauley, Marvin D Jones, Mary F Bodick, Massoud Motamed, Matthew A Johnson, Matthew J Hansen, Matthew M Vernon, Matthew R Dionne, Matthew R Mcnew, Melissa F Chauvin, Michael A Charles, Michael E Maselli, Michael Gu, Michael J Kuchta, Michael Kuchta, Michael R Goga, Michael S Araneta, Michelle D Motsinger, Mihaly S Ligmond, Milinda F Soukup, Misty L Treece, Morie Alpha, Mra M Barbosar, Mra Mcculloughj, Myckie M Jacobsen, Nalini D Lebzelter, Nancy G Schmidt, Nancy L Meade, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Neira Acevedo Ramos, Nicholas L Hunt, Nicole K Trudel, Nicole T Williams, Niketa Patel, Oluwaseyi Ojinni, Omotunde O Osunsanmi, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Patricia D Stahnke, Patrick L Wisor, Paul J Teitell, Paul Lihong Yeh, PhD, Paul Perdue (NMI), Jr, Paul Z Balcer, Paula A Trost, Philip E Ake, Prabhu P Raju, Rebecca H Lee, Rebecca L Mullikin, Reyes Candau Chacon, PhD, Richard Heath Coats, Richard T Jensen, Richard W Thornton, Ricki A Chase, Ricki Achase Off, Robert D Tollefsen, Robert J Burger, Robert Sharpnack, Rochelle L Cross, Roger F Zabinski, Roger L Farmer, Rose M Ashley, Rose Xu, Rowena S Nguyen, Russell K Riley, S Alexander Hamblin, Saied A Asbagh, Samantha E Rafferty, Samuel A Hamblin, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah E Mcmullen, Scott T Ballard, Secrist, Seneca D Toms, Sharon K Thoma, PharmD, Sheila Alaghemand, Sherbet Samuels, Shererk, Sidney B Priesmeyer, Siobhan G Taylor, Sripal R Mada, PhD, State Agency, Stefanie R Cook, Stephen T Hansen, Steve P Yost, Steve Y Rhieu, PhD, Steven C Madzo, Steven M Weinman, Steven O Gauthier, Susan F Laska, MS, Susan M Jackson, Swati Kabaria, Tamara L Setzer, Tara G Bizjak, Tara L Breckenridge, Tara L Greene, Tara R Gooen, Teena H Aiken, Tenzin Jangchup, Terri L Dodds, Terri L Thomas, Thai T Duong, Theressa B Smith, Thomas J Arista, Thomas S Arista, Thomas V Anderson, Toni L Morales, Trevor R Beach, Uduak M Inokon, Valerie L Whipp, Verlinda A Narcisse, Vicky L Cruz, Walden H Lee, Wayne S Fortenberry, Wayne T Smith, Wayne W Grundstrom, Wdouglas Rowe, Wendy G Tan, PhD, William A Lanier, Yiyue Zhang (nmi), PhD, Yumi J Hiramine, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zachey L Miller, Zhong Li, PhD

Kimberley A Hoefen's Documents

Publish Date Document Type Title
May, 2012 EIR Corden Pharma Boulder, Inc. - EIR, 2012-05-11
September, 2010 FDA 483 Amgen, Incorporated - Form 483, 2010-09-03
February, 2014 FDA 483 N.V. Organon - Form 483, 2014-02-07
March, 2014 FDA 483 US Compounding Inc - Form 483, 2014-03-27
March, 2014 EIR US Compounding Inc - EIR, 2014-03-27
May, 2011 FDA 483 Sandoz Incorporated - Form 483, 2011-05-06
October, 2012 FDA 483 Cody Laboratories, Inc. - Form 483, 2012-10-12
February, 2013 FDA 483 Genesis Alkali Wyoming, LP - Form 483, 2013-02-14
August, 2013 FDA 483 Front Range Laboratories, Inc. - Form 483, 2013-08-30
January, 2014 EIR Nelson Laboratories, LLC - EIR, 2014-01-10
April, 2015 EIR Xcaliber International, LTD., LLC. - EIR, 2015-04-21
August, 2012 FDA 483 Sandoz Incorporated - Form 483, 2012-08-14
May, 2013 EIR Orion Corporation - EIR, 2013-05-24
December, 2014 EIR Tantus Tobacco LLC - EIR, 2014-12-03
February, 2015 EIR American Packaging Corporation Rotogravure Ctr of Excellence - EIR, 2015-02-24
June, 2012 EIR Actavis Laboratories UT, Inc. - EIR, 2012-06-08
June, 2013 EIR Corden Pharma Colorado, Inc. - EIR, 2013-06-28
September, 2015 EIR Skookum Creek Tobacco Co., Inc. - EIR, 2015-09-02
September, 2010 FDA 483 Amgen, Inc. - Form 483, 2010-09-03
June, 2014 EIR U.S. Flue Cured Tobacco Growers Inc - EIR, 2014-06-11
August, 2012 EIR Sandoz Incorporated - EIR, 2012-08-14
February, 2013 EIR Aliri USA Inc. - EIR, 2013-02-20
June, 2011 EIR Corden Pharma Boulder, Inc. - EIR, 2011-06-21
January, 2012 EIR Amgen, Incorporated - EIR, 2012-01-06
May, 2013 FDA 483 New Vistas Inc. - Form 483, 2013-05-10
June, 2011 FDA 483 Alera Technologies, Inc. - Form 483, 2011-06-10
April, 2011 FDA 483 Similasan Corporation - Form 483, 2011-04-08
April, 2009 FDA 483 Regenerative Sciences, LLC - Form 483, 2009-04-15
May, 2012 FDA 483 Corden Pharma Boulder, Inc. - Form 483, 2012-05-11
March, 2012 EIR Fresenius Medical Care North America - EIR, 2012-03-08
August, 2013 FDA 483 American National Red Cross - Form 483, 2013-08-30
June, 2013 FDA 483 Syntrion Gmbh - Form 483, 2013-06-13
January, 2012 EIR Amgen, Inc. - EIR, 2012-01-06
January, 2012 FDA 483 Response Amgen, Incorporated - Form 483R, 2012-01-20
May, 2010 FDA 483 New Generation Wellness - Form 483, 2010-05-25
June, 2013 FDA 483 Corden Pharma Colorado, Inc. - Form 483, 2013-06-28
April, 2012 FDA 483 Curia New Mexico, LLC - Form 483, 2012-04-19
June, 2011 FDA 483 Corden Pharma Boulder, Inc. - Form 483, 2011-06-21
June, 2012 FDA 483 Actavis Laboratories UT, Inc. - Form 483, 2012-06-08
September, 2010 EIR Amgen, Inc. - EIR, 2010-09-03
February, 2015 EIR Sherman's 1400 Broadway, N.Y.C. LLC. - EIR, 2015-02-11
January, 2012 FDA 483 Amgen, Inc. - Form 483, 2012-01-06
March, 2012 FDA 483 Fresenius Medical Care North America - Form 483, 2012-03-08
August, 2011 FDA 483 Curia New Mexico, LLC - Form 483, 2011-08-16
January, 2012 FDA 483 Amgen, Incorporated - Form 483, 2012-01-06
March, 2016 EIR S & M Brands, Inc. - EIR, 2016-03-09
November, 2011 FDA 483 The Synergy Company of Utah, LLC - Form 483, 2011-11-18
November, 2015 EIR Sandia Tobacco Manufacturers, Inc. - EIR, 2015-11-03
September, 2012 FDA 483 TOLMAR INC - Form 483, 2012-09-07
September, 2010 EIR Amgen, Incorporated - EIR, 2010-09-03
May, 2011 FDA 483 Response Sandoz Incorporated - Form 483R, 2011-05-31
December, 2014 EIR Southern Cross Tobacco Company, INC. - EIR, 2014-12-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more